Gabapentin for Night Sweats: What to Expect
SaveGabapentin can reduce night sweats for some women and is usually taken at bedtime because it causes drowsiness. It is an off-label, nonhormone option that guidelines recommend when hormone therapy is unsuitable, though it eases hot flashes less completely than estrogen. Daytime grogginess is the most common tradeoff.
Last updated: July 2026
What does gabapentin do for night sweats?
Gabapentin is a medicine first developed for seizures and nerve pain that clinicians also use off-label to calm hot flashes and night sweats 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.. It is not a hormone, so it appeals to people who cannot use estrogen or prefer to avoid it 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.. The exact way it eases vasomotor symptoms is not fully understood, though it appears to steady the brain's temperature-control center. Because it causes drowsiness, clinicians often reserve it for symptoms that flare at night, when a calming, sleep-promoting effect is welcome rather than a nuisance 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.. Hormone therapy still relieves hot flashes more completely than any nonhormone medicine 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Establishes that systemic hormone therapy is the most effective treatment for vasomotor symptoms, framing gabapentin as an option when hormones are unsuitable or unwanted..
How well does gabapentin work at night?
Clinical trials show gabapentin reduces the frequency and severity of hot flashes more than a placebo, though the effect is generally modest and smaller than hormone therapy 3Ref 3Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015).Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147).AHRQ comparative-effectiveness review finds gabapentin reduces vasomotor symptoms more than placebo but works less reliably than estrogen.2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Establishes that systemic hormone therapy is the most effective treatment for vasomotor symptoms, framing gabapentin as an option when hormones are unsuitable or unwanted.. The North American Menopause Society lists it among the nonhormone options it recommends for bothersome vasomotor symptoms 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.. A 2015 comparative-effectiveness review from the Agency for Healthcare Research and Quality reached a similar conclusion, finding it helps some women but works less reliably than estrogen 3Ref 3Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015).Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147).AHRQ comparative-effectiveness review finds gabapentin reduces vasomotor symptoms more than placebo but works less reliably than estrogen.. Results vary from person to person, and the benefit is easier to judge after a few weeks of use.
For women who wake drenched night after night, the sedating quality can be an advantage, and it may also support better sleep.
What are the tradeoffs and side effects?
Daytime drowsiness, dizziness, and a foggy, hungover feeling are the most common downsides, especially over the first 2 weeks 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.3Ref 3Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015).Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147).AHRQ comparative-effectiveness review finds gabapentin reduces vasomotor symptoms more than placebo but works less reliably than estrogen.. Concentrating the dose at bedtime lines the sedation up with sleep and often eases daytime grogginess. Less often, some people notice mild leg swelling, unsteadiness, or trouble concentrating. Because the kidneys clear gabapentin, clinicians adjust it carefully for anyone with reduced kidney function 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.. Stopping it abruptly after regular use can occasionally cause rebound symptoms, so a gradual, clinician-guided taper is typical. For many women the sedation that makes gabapentin useful at night is the same thing that makes it hard to use by day.
How does gabapentin compare with other choices?
Hormone therapy relieves hot flashes more completely than any nonhormone medicine, so gabapentin is usually considered when hormones are unsuitable or unwanted 2Ref 2The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Establishes that systemic hormone therapy is the most effective treatment for vasomotor symptoms, framing gabapentin as an option when hormones are unsuitable or unwanted.. Among nonhormone options, low-dose antidepressants and the newer targeted medicine fezolinetant are alternatives, each with a different side-effect profile 1Ref 1The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.. Symptoms and priorities shift across the transition: in perimenopause, when periods still come, sleep-wrecking night sweats may be the loudest complaint, while later some women weigh bone and heart effects differently. Because vasomotor symptoms last a median of about 7.4 years, and beyond 10 years for some women, the plan often changes over time 4Ref 4Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015).Duration of menopausal vasomotor symptoms over the menopause transition.SWAN cohort study documents a median total vasomotor-symptom duration of about 7.4 years, extending beyond 10 years for some women, so treatment plans are revisited over time..
You can read more about hot flashes at night and how they relate to hormone therapy.
When night sweat treatment choices need a clinician
A clinician can weigh whether gabapentin, another nonhormone medicine, or hormone therapy best matches your symptoms, sleep, and health history. This conversation matters most when night sweats disrupt sleep for more than 2 weeks, when other medicines cause side effects, or when you also manage kidney problems or take sedating drugs. A primary care clinician or menopause specialist can review the full picture and explain how long treatment might continue.
Because menopause symptoms often persist for years, plans are usually revisited over time. Gale can help you prepare for that conversation.
Common questions
Related
Menopause & midlife
Clinical Hypnosis for Hot Flashes: The EvidenceMenopause & midlife
Fezolinetant (Veozah): A Non-Hormonal OptionMenopause & midlife
SSRIs for Hot Flashes: How Well They Work
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When night sweats need a closer look
- —Night sweats paired with unexplained weight loss, fever, or swollen glands are a reason to seek clinician review, since they can point to causes beyond menopause
- —New chest pain, a racing heartbeat, or fainting alongside sweats is a reason to seek prompt medical care
- —Severe daytime drowsiness, confusion, or unsteadiness after starting a new medicine is a reason to contact your prescriber promptly
- —Yellowing skin, dark urine, or new swelling after starting any treatment is a reason to seek clinician review
This article is general health education, not medical advice. Whether gabapentin suits you depends on your symptoms, health history, and other medicines, and that decision belongs with a prescribing clinician such as a primary care physician or menopause specialist.
References
- 1.The North American Menopause Society (Menopause Society) (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002200 ✓The 2023 NAMS nonhormone position statement includes gabapentin among recommended nonhormone options for menopausal vasomotor symptoms and notes its sedating, sleep-promoting effect suits night-time symptoms; kidney clearance requires dose adjustment.
- 2.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Establishes that systemic hormone therapy is the most effective treatment for vasomotor symptoms, framing gabapentin as an option when hormones are unsuitable or unwanted.
- 3.Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015). Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147). Agency for Healthcare Research and Quality (AHRQ). PMID 25905155 ✓AHRQ comparative-effectiveness review finds gabapentin reduces vasomotor symptoms more than placebo but works less reliably than estrogen.
- 4.Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. doi:10.1001/jamainternmed.2014.8063 ✓SWAN cohort study documents a median total vasomotor-symptom duration of about 7.4 years, extending beyond 10 years for some women, so treatment plans are revisited over time.
4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy